After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.

Study points to approach to improving anti-VEGF therapy for all wet AMD patients, and help subset of patients who lose vision ...

Lonza has continued to adapt to the evolving ADC landscape, including the recent addition of a highly potent vial fill ...

Synthetic genes, though few, can generate complex biomolecular materials when their expression is part of a temporal control ...

A new study shows the ketogenic diet increases anti-inflammatory compounds in mouse model of multiple sclerosis.